diclofenac sodium 75 MG Delayed Release Oral Tablet
INDICATIONS AND USAGE Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals ( see WARNINGS; Gastrointestinal Bleeding, Ulceration, and Perforation ). Diclofenac is indicated: For relief of the signs and symptoms of osteoarthritis For relief of the signs and symptoms of rheumatoid arthritis For acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis
Carlsbad Technology, Inc.
ROUND WHITE CTI 103
Related Pills
diclofenac sodium tablet delayed release
AvKARE, Inc.
diclofenac sodium tablet delayed release
AvKARE, Inc.
diclofenac sodium tablet delayed release
avkare, inc.
Diclofenac Sodium 75 MG Delayed Release Oral Tablet
AvKARE, Inc.
Diclofenac Sodium 75 MG Delayed Release Oral Tablet
AvKARE, Inc.
Diclofenac Sodium 75 MG Delayed Release Oral Tablet
AvKARE, Inc.
Diclofenac Sodium 75 MG Delayed Release Oral Tablet
AvKARE, Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
DICLOFENAC SODIUM delayed-release tablets 50 mg – white to off-white, biconvex, round-shaped, unscored (imprinted on one side), supplied in bottles of 60, 100 and 1000. Bottles of 60 ..................................................................NDC 61442-102-60 Bottles of 100 ................................................................NDC 61442-102-01 Bottles of 1000 ..............................................................NDC 61442-102-10 75 mg -– white to off-white, biconvex, round shaped, unscored (imprinted on one side), supplied in bottles of 60, 100, 500 and 1000. Bottles of 60 ..................................................................NDC 61442-103-60 Bottles of 100 ................................................................NDC 61442-103-01 Bottles of 500 ................................................................NDC 61442-103-05 Bottles of 1000 ..............................................................NDC 61442-103-10 Store at room temperature 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from moisture. Dispense in tight container (USP). Manufactured and Distributed by: Carlsbad Technology, Inc. 5923 Balfour Court Carlsbad, CA 92008 USA Revised: 07/2024 CTI-11 Rev. L dic05-0006-03 dic05-0006-04
More pills like ROUND CTI 103